Home
Aurobindo Pharma Ltd Board of Directors
Board of Directors at Aurobindo Pharma Ltd
Deepali Joshi
Independent Director
Girish Vanvari
Independent Director
Kambam Reddy
Vice Chairman & M.D.
M Madan Mohan Reddy
Whole-time Director
M Kumar
Chairman & Independent Directo
Key Highlights
- Kambam Nityananda Reddy continues to serve as the Vice Chairman & Managing Director in 2025, maintaining the same position as in the previous year.
- M Madan Mohan Reddy continues to serve as the Whole-time Director in 2025, maintaining the same position as in the previous year.
- P V Ramprasad Reddy continues to serve as the Non Executive Director in 2025, maintaining the same position as in the previous year.
- Girish Paman Vanvari continues to serve as the Independent Director in 2025, maintaining the same position as in the previous year.
- P Sarath Chandra Reddy joins the board as Non Executive Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Aurobindo Pharma Ltd
NSE: AUROPHARMA
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 26 Aug 2025 | 1045.3 |
| 25 Aug 2025 | 1067.35 |
| 22 Aug 2025 | 1050.25 |
| 21 Aug 2025 | 1040.3 |
| 20 Aug 2025 | 1046 |
| 19 Aug 2025 | 1090.3 |
| 18 Aug 2025 | 1090 |
| 14 Aug 2025 | 1082.9 |
| 13 Aug 2025 | 1077.15 |
| 12 Aug 2025 | 1058 |
Company Fundamentals for Aurobindo Pharma Ltd
Market Cap
61,248 Cr
EPS
57.9
P/E Ratio (TTM)
18.1
P/B Ratio (TTM)
1.9
Day’s High
1066.2
Day’s Low
1043.0
DTE
0.3
ROE
10.7
52 Week High
1592.55
52 Week Low
994.35
ROCE
13.5
Market Price of Aurobindo Pharma Ltd
1M
1Y
3Y
5Y
Monitoring Aurobindo Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Aurobindo Pharma Ltd News Hub
Aurobindo Pharma tumbles after US FDA issues warning letter to Telangana unit
In May 2024, the United States Food and Drug Administration (US FDA) had conducted an inspection at
Read more
16 Aug 24
Eugia Pharma Specialities receives USFDA warning for Unit III
Aurobindo Pharma announced that the USFDA has issued a warning letter for Unit-III of Eugia Pharma S
Read more
16 Aug 24
Aurobindo Pharma consolidated net profit rises 61.05% in the June 2024 quarter
Net profit of Aurobindo Pharma rose 61.05% to Rs 919.22 crore in the quarter ended June 2024 as agai
Read more
12 Aug 24
Auro Pharma Q3 PAT slides 10% YoY to Rs 846 crore
However, revenue from operations increased 8.53% year on year (YoY) to Rs 7,978.52 crore in the quar
Read more
07 Feb 25
Document
Popular Search
FAQs for Board of Directors of Aurobindo Pharma Ltd
How are members of Aurobindo Pharma Ltd Board of Directors selected?
Members of the Aurobindo Pharma Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Aurobindo Pharma Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Aurobindo Pharma Ltd Board of Directors?
Shareholders can interact with the Aurobindo Pharma Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Aurobindo Pharma Ltd Board of Directors meet?
The Aurobindo Pharma Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Aurobindo Pharma Ltd Board of Directors?
The Aurobindo Pharma Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Aurobindo Pharma Ltd?
The current Board of Directors at Aurobindo Pharma Ltd includes Kambam Nityananda Reddy( Vice Chairman & Managing Director) ,M Madan Mohan Reddy( Whole-time Director) ,P V Ramprasad Reddy( Non Executive Director) ,Girish Paman Vanvari( Independent Director) ,P Sarath Chandra Reddy( Non Executive Director) . The full list can be found on Aurobindo Pharma Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
